Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGS-1C4D4 plus gemcitabine in metastatic pancreatic cancer
NCT00902291Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of AGS-1C4D4 in pancreatic cancer (PC), sponsored by Astellas Pharma. Started Apr 2009; status: completed.
02
Drugs
AGS-1C4D4
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00902291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902291.